Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.creator | Rocha, Clarissa Ribeiro Reily | - |
Autor(es): dc.creator | Garcia, Camila Carrião Machado | - |
Autor(es): dc.creator | Vieira, D. B. | - |
Autor(es): dc.creator | Quinet, Annabel | - |
Autor(es): dc.creator | Lima, Leonardo Carmo de Andrade | - |
Autor(es): dc.creator | Munford, Veridiana | - |
Autor(es): dc.creator | Belizário, José Ernesto | - |
Autor(es): dc.creator | Menck, Carlos Frederico Martins | - |
Data de aceite: dc.date.accessioned | 2019-11-06T13:34:52Z | - |
Data de disponibilização: dc.date.available | 2019-11-06T13:34:52Z | - |
Data de envio: dc.date.issued | 2015-09-22 | - |
Data de envio: dc.date.issued | 2015-09-22 | - |
Data de envio: dc.date.issued | 2014 | - |
Fonte completa do material: dc.identifier | http://www.repositorio.ufop.br/handle/123456789/5611 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/558608 | - |
Descrição: dc.description | Malignant glioma is a severe type of brain tumor with a poor prognosis and few options for therapy. The main chemotherapy protocol for this type of tumor is based on temozolomide (TMZ), albeit with limited success. Cisplatin is widely used to treat several types of tumor and, in association with TMZ, is also used to treat recurrent glioma. However, several mechanisms of cellular resistance to cisplatin restrict therapy efficiency. In that sense, enhanced DNA repair, high glutathione levels and functional p53 have a critical role on cisplatin resistance. In this work, we explored several mechanisms of cisplatin resistance in human glioma. We showed that cellular survival was independent of the p53 status of those cells. In addition, in a host-cell reactivation assay using cisplatin-treated plasmid, we did not detect any difference in DNA repair capacity. We demonstrated that cisplatin-treated U138MG cells suffered fewer DNA double-strand breaks and DNA platination. Interestingly, the resistant cells carried higher levels of intracellular glutathione. Thus, preincubation with the glutathione inhibitor buthionine sulfoximine (BSO) induced massive cell death, whereas N-acetyl cysteine, a precursor of glutathione synthesis, improved the resistance to cisplatin treatment. In addition, BSO sensitized glioma cells to TMZ alone or in combination with cisplatin. Furthermore, using an in vivo model the combination of BSO, cisplatin and TMZ activated the caspase 3–7 apoptotic pathway. Remarkably, the combined treatment did not lead to severe side effects, while causing a huge impact on tumor progression. In fact, we noted a remarkable threefold increase in survival rate compared with other treatment regimens. Thus, the intracellular glutathione concentration is a potential molecular marker for cisplatin resistance in glioma, and the use of glutathione inhibitors, such as BSO, in association with cisplatin and TMZ seems a promising approach for the therapy of such devastating tumors. | - |
Idioma: dc.language | en | - |
Direitos: dc.rights | The article has been distributed under a Creative Commons CC-BY license that permit reuse this material without obtaining permission from Nature Publishing Group, providing that the author and the original source of publication are fully acknowledged. Fonte RigthLink. Acesso em 25 mai 2015. | - |
Título: dc.title | Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo. | - |
Aparece nas coleções: | Repositório Institucional - UFOP |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: